1-2 of 2
Zihai Li
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Converting Tumoral PD-L1 into a 4-1BB Agonist for Safer and More Effective Cancer Immunotherapy

Zihai Li, Joseph H. Azar, Mark P. Rubinstein
Journal: Cancer Discovery
Cancer Discov (2022) 12 (5): 1184–1186.
https://doi.org/10.1158/2159-8290.CD-22-0219
Published: 02 May 2022
View article titled, Converting Tumoral PD-L1 into a 4-1BB Agonist for Safer and More Effective Cancer Immunotherapy
Open the PDF for Converting Tumoral PD-L1 into a 4-1BB Agonist for Safer and More Effective Cancer Immunotherapy in another window
Includes: Supplementary data
Journal Articles

PRMT5 Is Required for Lymphomagenesis Triggered by Multiple Oncogenic Drivers

Yan Li, Nilesh Chitnis, Hiroshi Nakagawa, Yoshiaki Kita, Shoji Natsugoe, Yi Yang, Zihai Li, Mariusz Wasik, Andres J.P. Klein-Szanto, Anil K. Rustgi, J. Alan Diehl
Journal: Cancer Discovery
Cancer Discov (2015) 5 (3): 288–303.
https://doi.org/10.1158/2159-8290.CD-14-0625
Published: 05 March 2015
View article titled, PRMT5 Is Required for Lymphomagenesis Triggered by Multiple Oncogenic Drivers
Open the PDF for PRMT5 Is Required for Lymphomagenesis Triggered by Multiple Oncogenic Drivers in another window
Includes: Supplementary data